GLP-1 receptor agonists show promise in reducing cancer risk and enhancing early detection, highlighting the need for further research in oncology.
Dax Kurbegov, MD
Dax Kurbegov, MD, is senior vice president at HCA Healthcare Sarah Cannon Cancer Network, of the Sarah Cannon Research Institute.
Articles by Dax Kurbegov, MD
Dax Kurbegov, MD, discusses findings from the CORE-HH study that build on growing evidence to support the clinical feasibility of blood-based early detection tools.